Hypertension Stocks List

Hypertension Stocks Recent News

Date Stock Title
May 3 PFE Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
May 3 UTHR 30 Most Profitable Companies with Highest Margins in the World
May 3 KROS Keros Therapeutics files automatic mixed shelf
May 3 PFE Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
May 3 AZN Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
May 3 AZN Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
May 3 PFE Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3 SNY Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
May 3 PFE Here's Why Pfizer (PFE) is a Strong Momentum Stock
May 3 MDT Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
May 3 PFE Q1 2024 Cardiff Oncology Inc Earnings Call
May 3 PFE NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
May 3 AZN AstraZeneca reports positive interim data from mantle cell lymphoma trial
May 3 SNY Q1 2024 Kymera Therapeutics Inc Earnings Call
May 2 UTHR United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
May 2 UTHR United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
May 2 PFE Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
May 2 SNY Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
May 2 MDT Shareholders in Medtronic (NYSE:MDT) are in the red if they invested three years ago
May 2 MLYS Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024
Hypertension

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. High blood pressure typically does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.High blood pressure is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary, defined as high blood pressure due to nonspecific lifestyle and genetic factors. Lifestyle factors that increase the risk include excess salt in the diet, excess body weight, smoking, and alcohol use. The remaining 5–10% of cases are categorized as secondary high blood pressure, defined as high blood pressure due to an identifiable cause, such as chronic kidney disease, narrowing of the kidney arteries, an endocrine disorder, or the use of birth control pills.Blood pressure is expressed by two measurements, the systolic and diastolic pressures, which are the maximum and minimum pressures, respectively. For most adults, normal blood pressure at rest is within the range of 100–130 millimeters mercury (mmHg) systolic and 60–80 mmHg diastolic. For most adults, high blood pressure is present if the resting blood pressure is persistently at or above 130/80 or 140/90 mmHg. Different numbers apply to children. Ambulatory blood pressure monitoring over a 24-hour period appears more accurate than office-based blood pressure measurement.Lifestyle changes and medications can lower blood pressure and decrease the risk of health complications. Lifestyle changes include weight loss, physical exercise, decreased salt intake, reducing alcohol intake, and a healthy diet. If lifestyle changes are not sufficient then blood pressure medications are used. Up to three medications can control blood pressure in 90% of people. The treatment of moderately high arterial blood pressure (defined as >160/100 mmHg) with medications is associated with an improved life expectancy. The effect of treatment of blood pressure between 130/80 mmHg and 160/100 mmHg is less clear, with some reviews finding benefit and others finding unclear benefit. High blood pressure affects between 16 and 37% of the population globally. In 2010 hypertension was believed to have been a factor in 18% of all deaths (9.4 million globally).

Browse All Tags